In this CME Outfitters recorded symposium, faculty will examine the role of pro-inflammatory cytokines in the pathogenesis of IBD, discern differences in IL-23 binding among IL-23p19–targeted therapies, assess the safety and efficacy of IL-23p19–targeted therapies for the treatment of IBD, and explore when to incorporate IL-23p19–targeted therapies into the management of patients with IBD.

In this first of four CME Outfitters Snacks, expert faculty will share guideline recommendations and best practices for optimizing initial screening and risk stratification of patients at risk for MASH.

This second of four CME Outfitters Snacks features metabolic dysfunction-associated steatotic liver disease (MASLD) / metabolic-associated steatohepatitis (MASH) experts Monica Tincopa, MD, and Amreen Dinani, MD.

In this CME Outfitters Snack on metabolic dysfunction-associated steatotic liver disease (MASLD) / metabolic-associated steatohepatitis (MASH), expert faculty turn attention to treatment planning for Mr. B, who has been diagnosed with MASH. Discussion centers on evidence-based lifestyle interventions, including nutrition and physical activity, and integrates the latest data on recently approved therapies that are clinically relevant to Mr. B’s case. Faculty also highlight key recommendations from the 2025 American Diabetes Association (ADA) MASLD Guideline, reviewing the liver, cardiometabolic, and cardiorenal effects of other glucose-lowering agents not yet specifically approved for MASLD/MASH. The program concludes with a practical look at the interprofessional care team, emphasizing collaboration among clinicians managing patients with diabetes and MASLD/MASH.

In this CME Outfitters infographic, expert faculty will implement evidence-based strategies for early and accurate diagnosis of PBC and model implementation of contemporary clinical pathways for treating PBC that address biochemical response and symptoms (e.g. pruritus, fatigue). Learners will be guided through assessment of new and emerging therapeutic pathways for PBC and their potential impact on patient outcomes.

This fourth Snack in the series features experts Naim Alkhouri, MD, and Monica Tincopa, MD, MSc, who together provide practical insights and forward-looking perspectives on where MASH management is headed and what to anticipate in clinical practice.

This CME Outfitters Snack activity is the first in the four-part series Linking Knowledge to Action: Empowering HCPs in Screening and Treatment of Patients Across the Viral Hepatitis Spectrum. The series is led by moderators Su Wang, MD (USA) and Heiner Wedemeyer, MD (Germany), with expert discussants Jean-Michel Pawlotsky, MD, PhD (France), Maria Buti, MD, PhD (Spain), George Lau, MD (Hong Kong) and Debika Bhattacharya, MD (USA).

This CME Outfitters Snack activity is the third in the four-part series Linking Knowledge to Action: Empowering HCPs in Screening and Treatment of Patients Across the Viral Hepatitis Spectrum. The series is led by moderators Su Wang, MD (USA) and Heiner Wedemeyer, MD (Germany), with expert discussants Jean-Michel Pawlotsky, MD, PhD (France), Maria Buti, MD, PhD (Spain), George Lau, MD (Hong Kong) and Debika Bhattacharya, MD (USA).

This CME Outfitters Snack activity is the second in the four-part series Linking Knowledge to Action: Empowering HCPs in Screening and Treatment of Patients Across the Viral Hepatitis Spectrum. The series is led by moderators Su Wang, MD (USA) and Heiner Wedemeyer, MD (Germany), with expert discussants Jean-Michel Pawlotsky, MD, PhD (France), Maria Buti, MD, PhD (Spain), George Lau, MD (Hong Kong), and Debika Bhattacharya, MD (USA).

This activity is the final installment in the CME Outfitters Snack series on global viral hepatitis. The series is led by moderators Su Wang, MD (USA) and Heiner Wedemeyer, MD (Germany), with expert discussants Jean-Michel Pawlotsky, MD, PhD (France), Maria Buti, MD, PhD (Spain), George Lau, MD (Hong Kong) and Debika Bhattacharya, MD (USA).

In this CME Outfitters BriefCase, expert faculty will identify how the complex, Th2-driven pathophysiology of EoE impacts diagnosis and treatment and integrate evidence-based treatments into the care of patients with EoE based on clinical trial data. Faculty will model development of long-term care plans for patients with EoE to address the chronic, progressive nature of this disease.

In this CME Outfitters BriefCase, Drs. Peek and Quezada will guide learners through a patient case scenario reflective of the impact of biases, disparities, and health inequities that exist in racial and ethnic underserved patients with IBD. This program will provide actionable strategies, empowering attendees to recognize social determinants of health and implement changes in practice to improve IBD treatment.

In this podcast installment of a multi-prong diversity, equity, and inclusion (DEI) series, Monica E. Peek, MD, MPH, MSc; Sophie Balzora, MD, FACG; and Nana Bernasko, CRNP, DNP, WHNP-BC, will discuss strategies vital to combating inequities in IBD. The conversation will describe modern-day issues in how unconscious bias, health disparities, and health inequities all influence quality of care, and will provide real-world strategies to improve IBD care for all patients.

In this CMEO BriefCase, expert faculty will utilize case-based learning to illustrate these pervasive disparities through the stories of two patients, Harold and April, while offering strategies to address inequities in the treatment and outcomes of patients with IBD.

In this CME Outfitters BriefCase, part of a collection on health equity, expert faculty will explore strategies to improve health equity in gastrointestinal care. The focus will be on understanding upstream, midstream, and downstream drivers of health inequities, such as socioeconomic status, immigration status, and lack of social support. Learners will gain actionable strategies, including utilizing case managers, interpreter services, culturally aligned dieticians, and community support workers to address social drivers of health. These strategies aim to improve diagnosis, treatment, and outcomes for underserved populations, fostering equitable gastrointestinal care delivery.

This fast-paced recorded CaseWise™ symposium from CME Outfitters will bring real-world clinical decision-making to life. Through dynamic patient cases, learners will compare their treatment choices to those of leading experts, peers in the room, providers in the community, patients themselves, and even AI-based insights. Learners will see how evidence translates into practice, what doesn’t, and why. Designed to challenge assumptions and sharpen strategy, this immersive format empowers clinicians to immediately apply the latest IL-23 inhibitor data, enhance communication and shared decision-making, and deliver truly patient-centered IBD care.